I think nobody made an approach for the IIH franchise, because it would have been reasonable to assume, as we all did, that that the board would not sell until the readout of the Phase III.
However, I don't think it will go to big Pharma. Despite being removed from the board Prof Sinclair is still the primary investigator for the Evolve trial and this represents a decade of her work, she will play the key role in determining where this asset goes. I am certain nobody will buy the IIH assets unless she and the team at the Uni of Birmingham are onboard. Hence my view that Peptron will step up as she would have been instrumental in selecting them. Might be a different case for TBI given it is at such an early stage.
- Forums
- ASX - By Stock
- IXC
- Ann: Director Resignations and Appointment of Non-Executive Chair
Ann: Director Resignations and Appointment of Non-Executive Chair, page-25
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.0¢ |
Change
-0.002(2.78%) |
Mkt cap ! $5.561M |
Open | High | Low | Value | Volume |
7.4¢ | 7.6¢ | 7.0¢ | $7.077K | 100.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 7.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.071 |
1 | 62163 | 0.070 |
1 | 100000 | 0.063 |
1 | 100000 | 0.062 |
1 | 150000 | 0.060 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 5000 | 1 |
0.082 | 56058 | 1 |
0.083 | 4000 | 1 |
0.085 | 1000 | 1 |
0.090 | 126146 | 1 |
Last trade - 10.58am 30/07/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online